Tuberculosis Research and Epidemiology

149 works

1. Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011

   Dilrabo Ulmasova, G Uzakova, M N Tillyashayhov +17

   ArticleTuberculosis Research and EpidemiologyEurosurveillance201315 citations

   ABIABI:AkademIndex/openalex/2026.other.163910

2. Multidrug-resistant Tuberculosis in Central Asia

   Helen Cox, Juan Daniel Orozco, Roy Male +6

   ArticleTuberculosis Research and EpidemiologyEmerging infectious diseases20046 citations

   ABIABI:AkademIndex/openalex/2026.other.020023

3. A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

   Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis +15

   ArticleTuberculosis Research and EpidemiologyNew England Journal of Medicine20225 citations

   ABIABI:AkademIndex/openalex/2022.article.000002

4. Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study

   Jamshid Gadoev, Damin Asadov, Mirzagolib Tillashaykhov +14

   ArticleTuberculosis Research and EpidemiologyPLoS ONE20154 citations

   ABIABI:AkademIndex/openalex/2015.article.000023

5. Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

   Shona Horter, Beverley Stringer, Jane Greig +5

   ArticleTuberculosis Research and EpidemiologyBMC Infectious Diseases20164 citations

   ABIABI:AkademIndex/openalex/2016.article.000054

6. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses

   Faiz Ahmad Khan, M Salim, Philipp du Cros +9

   Review articleTuberculosis Research and EpidemiologyEuropean Respiratory Journal20174 citations

   ABIABI:AkademIndex/openalex/2017.review-article.000004

7. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

   James M. Trauer, Jay Achar, Nargiza Parpieva +7

   ArticleTuberculosis Research and EpidemiologyBMC Medicine20163 citations

   ABIABI:AkademIndex/openalex/2026.other.195695

8. Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan

   Shona Horter, Beverley Stringer, Nell Gray +5

   ArticleTuberculosis Research and EpidemiologyBMC Infectious Diseases20203 citations

   ABIABI:AkademIndex/openalex/2026.other.195708

9. Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan

   Parvati Nair, T. Hasan, K. K. Zaw +9

   ArticleTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20223 citations

   ABIABI:AkademIndex/openalex/2026.other.281624

10. ‘They prefer hidden treatment': anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan

    Beverley Stringer, Karen Lowton, Mirzagaleb N. Tillashaikhov +5

    ArticleTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20162 citations

    ABIABI:AkademIndex/openalex/2016.article.000087

11. Health system support and health system strengthening: two key facilitators to the implementation of ambulatory tuberculosis treatment in Uzbekistan

    Stefan Köhler, Damin Asadov, Andreas Bründer +4

    ArticleTuberculosis Research and EpidemiologyHealth Economics Review20162 citations

    ABIABI:AkademIndex/openalex/2016.article.000128

12. Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013–2018

    Khasan Safaev, Nargiza Parpieva, Irina Liverko +5

    ArticleTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20212 citations

    ABIABI:AkademIndex/openalex/2021.article.000207

13. Antituberculosis Activity and Pharmacokinetics of Polymer Conjugates of Isoniazid and Ethambutol

    Ш. А. Шомуротов, Oliy Ravshanovich Akhmedov, А. С. Тураев +1

    ArticleInfectious Diseases and TuberculosisPharmaceutical Chemistry Journal20212 citations

    ABIABI:AkademIndex/openalex/2021.article.001447

14. Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012–2019: Are We on the Right Track?

    Sharofiddin Yuldashev, Nargiza Parpieva, Salikhdjan Alimov +6

    ArticleTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20212 citations

    ABIABI:AkademIndex/openalex/2026.other.262609

15. Ambulatory tuberculosis treatment in post-Semashko health care systems needs supportive financing mechanisms

    Stefan Köhler, Damin Asadov, Andreas Bründer +4

    ArticleHIV/AIDS Impact and ResponsesThe International Journal of Tuberculosis and Lung Disease20142 citations

    ABIABI:AkademIndex/openalex/2026.other.364601

16. The Beijing genotype and drug resistant tuberculosis in the Aral Sea region of Central Asia

    Helen Cox, Tanja Kubica, Daribay Doshetov +3

    ArticleTuberculosis Research and EpidemiologyRespiratory Research20051 citations

    ABIABI:AkademIndex/openalex/2005.article.000006

17. Tuberculosis Recurrence and Mortality after Successful Treatment: Impact of Drug Resistance

    Helen Cox, Yared Kebede, Sholpan Allamuratova +8

    ArticleTuberculosis Research and EpidemiologyPLoS Medicine20061 citations

    ABIABI:AkademIndex/openalex/2006.article.000008

18. Delay in the diagnosis and treatment of pulmonary tuberculosis in Uzbekistan: a cross-sectional study

    Tatiana Belkina, Doniyor S Khojiev, Mirzagaleb Tillyashaykhov +4

    ArticleTuberculosis Research and EpidemiologyBMC Infectious Diseases20141 citations

    ABIABI:AkademIndex/openalex/2014.article.000040

19. Revised Definitions of Multidrug-Resistant Tuberculosis Treatment Outcomes: Closer to the Reality?

    Mathieu Bastard, Maryline Bonnet, Philipp du Cros +9

    OtherTuberculosis Research and EpidemiologyAmerican Journal of Respiratory and Critical Care Medicine20151 citations

    ABIABI:AkademIndex/openalex/2015.other.000002

20. Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan

    Johanna Kuhlin, Chris Smith, Atadjan Khaemraev +8

    ArticleTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20181 citations

    ABIABI:AkademIndex/openalex/2018.article.000181

21. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

    S.K. Abidi, Jay Achar, M.M. Assao Neino +34

    ArticleTuberculosis Research and EpidemiologyEuropean Respiratory Journal20191 citations

    ABIABI:AkademIndex/openalex/2019.article.000020

22. Population structure of drug-resistant Mycobacterium tuberculosis in Central Asia

    A. Engström, Uladzimir Antonenka, Abdylat Kadyrov +10

    ArticleTuberculosis Research and EpidemiologyBMC Infectious Diseases20191 citations

    ABIABI:AkademIndex/openalex/2019.article.000129

23. The study of life quality parameters in children and adolescents with HIV associated tuberculosis

    Динара Намазовна Аджаблаева

    ArticleTuberculosis Research and EpidemiologyTuberculosis and lung diseases20201 citations

    ABIABI:AkademIndex/openalex/2020.article.000868

24. Prevention Of Anemia In Patients With Tuberculosis

    Mamatkulova Feruza Xaydarovna, Mamatova Nargiza Toirjonovna, Ruziboeva Oyjamol Narzullaevna

    ArticleTuberculosis Research and EpidemiologyThe American Journal of Medical Sciences and Pharmaceutical Research20201 citations

    ABIABI:AkademIndex/openalex/2020.article.000973

25. Factors Associated with Unfavourable Treatment Outcomes in Patients with Tuberculosis: A 16-Year Cohort Study (2005–2020), Republic of Karakalpakstan, Uzbekistan

    Jamshid Gadoev, Damin Asadov, Anthony Harries +11

    ArticleTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20211 citations

    ABIABI:AkademIndex/openalex/2021.article.000489